Dr. Krystof Bankiewicz Brain Neurotherapy Bio, Inc. (BNB) announced the treatment of the first patient in clinical trial testing a new approach to treat Parkinson's using MRI-guided neurosurgery to inject gene therapy into damaged regions of the brain. This CIRM‑funded trial, led by Dr. Krystof Bankiewicz, is one of 64 clinical trials supported by the … Continue reading CIRM-funded clinical trial testing a new approach to treat Parkinson’s disease
Brain Neurotherapy Bio
Stem Cells for Parkinson’s Disease
While the world has been turned upside down by the coronavirus pandemic, the virus poses an increased threat to people with Parkinson’s disease (PD). Having a compromised immune system, particularly involving the lungs, means people with PD are at higher risk of some of the more dangerous complications of COVID-19. So, this seems like an … Continue reading Stem Cells for Parkinson’s Disease
Stem Cell Agency Approves Funding for Clinical Trials Targeting Parkinson’s Disease and Blindness
The governing Board of the California Institute for Regenerative Medicine (CIRM) yesterday invested $32.92 million to fund the Stem Cell Agency’s first clinical trial in Parkinson’s disease (PD), and to support three clinical trials targeting different forms of vision loss. This brings the total number of clinical trials funded by CIRM to 60. The PD … Continue reading Stem Cell Agency Approves Funding for Clinical Trials Targeting Parkinson’s Disease and Blindness